IDYAIDEAYA Biosciences, Inc.vs its industry peers
A metric-by-metric comparison of IDEAYA Biosciences, Inc. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDYAThis | $3.0B#8 | — | 2.8x#3 | 13.8x#4 | 3024.4%#2 | 58.6%#4 | -72.8%#4 | -10.4%#4 | — | — | -0.2%#10 | — |
| ACAD | $3.5B#1 | 9.2x#1 | 2.7x#2 | 3.3x#3 | 11.9%#5 | 73.0%#2 | 9.8%#3 | 29.9%#1 | 11.4%#1 | — | -8.0%#13 | — |
| DYN | $3.4B#2 | — | 4.8x#9 | — | — | -40.6%#14 | — | -0.0%#3 | -1301.5%#9 | — | -25.1%#15 | — |
| VKTX | $3.3B#3 | — | 5.7x#12 | — | — | -227.1%#16 | — | -61.1%#13 | — | — | -27.5%#16 | — |
| ELVN | $3.3B#4 | — | 3.7x#5 | — | — | -16.5%#9 | — | -11.6%#5 | — | — | 122.4%#2 | — |
| AMLX | $3.3B#5 | — | 13.6x#14 | — | -100.0%#10 | 52.0%#5 | — | -60.5%#12 | — | — | 115.2%#4 | — |
| IRON | $3.1B#6 | — | 4.8x#10 | — | — | -94.0%#15 | — | -32.9%#9 | -39.0%#5 | — | -4.1%#11 | — |
| BHC | $3.0B#7 | — | — | 0.3x#1 | 6.7%#6 | 441.3%#1 | 17.7%#2 | — | 3.7%#3 | — | 33.2%#6 | 11.7%#1 |
| VRDN | $2.8B#9 | — | 4.3x#6 | 40.2x#7 | 23359.9%#1 | -26.9%#11 | -512.9%#7 | -51.7%#11 | -54.5%#6 | — | 8.6%#8 | — |
| NRIX | $2.8B#10 | 10.6x#2 | 2.9x#4 | 33.6x#6 | 54.0%#3 | -36.6%#12 | -340.2%#6 | -27.3%#8 | — | — | 104.8%#5 | — |
| MBX | $2.7B#11 | — | 6.5x#13 | — | — | -40.5%#13 | — | -21.2%#7 | — | — | 166.7%#1 | — |
| RCUS | $2.4B#12 | — | 5.2x#11 | 73.0x#8 | -35.3%#9 | -24.7%#10 | -1169.7%#8 | -76.1%#14 | -93.0%#8 | — | -7.0%#12 | — |
| BHVN | $2.4B#13 | — | — | — | — | 12.7%#7 | — | — | — | — | 5.1%#9 | — |
| PBH | $2.3B#14 | 13.9x#3 | 1.2x#1 | 2.2x#2 | -4.3%#7 | -11.3%#8 | 28.4%#1 | 9.9%#2 | 5.9%#2 | 4#1 | -18.2%#14 | — |
| IMNM | $2.3B#15 | — | 4.4x#7 | 332.7x#9 | -23.2%#8 | 27.5%#6 | -3228.8%#9 | -40.4%#10 | -72.8%#7 | — | 19.4%#7 | — |
| XNCR | $2.3B#16 | — | 4.5x#8 | 18.2x#5 | 13.7%#4 | 60.5%#3 | -141.4%#5 | -18.3%#6 | -31.5%#4 | — | 120.4%#3 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice